These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors. Zhu CB, Lindler KM, Campbell NG, Sutcliffe JS, Hewlett WA, Blakely RD. Mol Pharmacol; 2011 Sep 01; 80(3):458-65. PubMed ID: 21705486 [Abstract] [Full Text] [Related]
25. Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter. Johnson MS, Lutz EM, Firbank S, Holland PJ, Mitchell R. Cell Signal; 2003 Aug 01; 15(8):803-11. PubMed ID: 12781873 [Abstract] [Full Text] [Related]
26. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Carneiro AM, Cook EH, Murphy DL, Blakely RD. J Clin Invest; 2008 Apr 01; 118(4):1544-52. PubMed ID: 18317590 [Abstract] [Full Text] [Related]
27. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Jayanthi LD, Samuvel DJ, Blakely RD, Ramamoorthy S. Mol Pharmacol; 2005 Jun 01; 67(6):2077-87. PubMed ID: 15774771 [Abstract] [Full Text] [Related]
28. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Kivell B, Day D, Bosch P, Schenk S, Miller J. Neuroscience; 2010 Jun 16; 168(1):82-95. PubMed ID: 20298763 [Abstract] [Full Text] [Related]
29. Enteropathogenic infections modulate intestinal serotonin transporter (SERT) function by activating Toll-like receptor 2 (TLR-2) in Crohn's disease. Qasem A, Naser AE, Naser SA. Sci Rep; 2021 Nov 19; 11(1):22624. PubMed ID: 34799637 [Abstract] [Full Text] [Related]
30. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. J Neurosci; 1997 Jan 01; 17(1):45-57. PubMed ID: 8987735 [Abstract] [Full Text] [Related]
31. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Robson MJ, Quinlan MA, Margolis KG, Gajewski-Kurdziel PA, Veenstra-VanderWeele J, Gershon MD, Watterson DM, Blakely RD. Proc Natl Acad Sci U S A; 2018 Oct 23; 115(43):E10245-E10254. PubMed ID: 30297392 [Abstract] [Full Text] [Related]
32. Regulation of the serotonin transporter by interacting proteins. Haase J, Killian AM, Magnani F, Williams C. Biochem Soc Trans; 2001 Nov 23; 29(Pt 6):722-8. PubMed ID: 11709063 [Abstract] [Full Text] [Related]
33. Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells. Barros LF, Young M, Saklatvala J, Baldwin SA. J Physiol; 1997 Nov 01; 504 ( Pt 3)(Pt 3):517-25. PubMed ID: 9401960 [Abstract] [Full Text] [Related]
34. The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Malynn S, Campos-Torres A, Moynagh P, Haase J. Neurochem Res; 2013 Apr 01; 38(4):694-704. PubMed ID: 23338678 [Abstract] [Full Text] [Related]
35. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Grethe S, Pörn-Ares MI. Cell Signal; 2006 Apr 01; 18(4):531-40. PubMed ID: 15972258 [Abstract] [Full Text] [Related]
36. Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter. Welsh DJ, Harnett M, MacLean M, Peacock AJ. Am J Respir Crit Care Med; 2004 Aug 01; 170(3):252-9. PubMed ID: 15087293 [Abstract] [Full Text] [Related]
37. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, Maassen JA. Mol Endocrinol; 2004 Jul 01; 18(7):1697-707. PubMed ID: 15184525 [Abstract] [Full Text] [Related]
38. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects. Larsen AK, Brennum LT, Egebjerg J, Sánchez C, Halldin C, Andersen PH. Br J Pharmacol; 2004 Mar 01; 141(6):1015-23. PubMed ID: 14993096 [Abstract] [Full Text] [Related]
39. A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Baganz NL, Lindler KM, Zhu CB, Smith JT, Robson MJ, Iwamoto H, Deneris ES, Hewlett WA, Blakely RD. Transl Psychiatry; 2015 Nov 03; 5(11):e671. PubMed ID: 26529424 [Abstract] [Full Text] [Related]
40. Enhanced activity of human serotonin transporter variants associated with autism. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD. Philos Trans R Soc Lond B Biol Sci; 2009 Jan 27; 364(1514):163-73. PubMed ID: 18957375 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]